Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-quadruplexes are four-stranded nucleic acid secondary structures that form in guanine-rich DNA or RNA sequences via stacks of G-tetrads held together by Hoogsteen hydrogen bonds and stabilized by monovalent cations. They are prevalent in telomeres, oncogene promoters (such as c-MYC), and regulatory regions of both DNA and RNA. G-quadruplex stabilization by small molecules (G4 ligands) can modulate gene expression, inhibit telomerase, and interfere with DNA replication or RNA function, making these structures potential targets in cancer and other diseases. However, their widespread distribution poses therapeutic challenges regarding specificity and safety
Ligand-mediated stabilization of G-quadruplexes in DNA or RNA leads to: Transcriptional repression of oncogenes (e.g., c-MYC); Disruption of telomerase activity and telomere maintenance; Modulation of RNA function by altering secondary structure and accessibility
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-quadruplex nucleic acid structure (G4).